LJB — Enzyme Linked Immunoabsorbent Assay, Rubeola Igg Class I

FDA Device Classification

FDA product code LJB covers "Enzyme Linked Immunoabsorbent Assay, Rubeola Igg", a Class I medical device regulated under 21 CFR 866.3520. Submissions are reviewed by the Microbiology panel. At least 11 recent 510(k) clearances have been granted under this product code.

Classification details

Product Code
LJB
Device Class
Class I
Regulation Number
866.3520
Submission Type
510(k) Exempt
Review Panel
MI
Medical Specialty
Microbiology
Implant
No

Definition

The qualitative detection of measles specific IgG antibodies in serum or plasma.

Recent 510(k) clearances

K-NumberApplicantDevice NameDate
K974552DiamedixDIAMEDIX IS-MEASLES IGG TEST SYSTEMJan 28, 1998
K971620Inova DiagnosticsQUANTA LITE RUBEOLA (MEASLES) IGGJul 22, 1997
K922335Baxter DiagnosticsBARTELS RUBEOLA IGM EIASep 2, 1992
K922330Baxter DiagnosticsBARTELS RUBEOLA IGG EIASep 2, 1992
K910290Virus Reference LaboratoryVIRATEST-DIA(TM) MEASLES (RUBEOLA)Mar 18, 1992
K904083Gull LaboratoriesRUBEOLA IGM ELISA TESTJan 3, 1991
K903961DiamedixMEASLES IGG MICROASSAYDec 28, 1990
K904854Gull LaboratoriesRUBEOLA IGG ELISA TESTDec 4, 1990
K891990Clinical SciencesRUBEOLA IGG CLIN-ELISA TEST SYSTEM, CAT. #4600Jun 15, 1989
K873925Electro-Nucleonics LaboratoriesVIRGO(TM) MEASLES IGG ELISAFeb 24, 1988
K821762M.A. BioproductsMEASELISA TEST KITJul 30, 1982

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.